The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 11,501–11,600 of 31,469
Gąsiorowska, A., Talar‐Wojnarowska, R., Kaczka, A., Borkowska, A., Czupryniak, L., & Malecka-Panas, E. I. (2013) · Pancreatology · doi:10.1016/j.pan.2013.04.198 · Cited by 30
Silva, A. P., Fragoso, A., Silva, C., et al. (2013) · BioMed Research International · doi:10.1155/2013/247649 · Cited by 30
Insulin Resistance as a Risk Factor for Gallbladder Stone Formation in Korean Postmenopausal Women
Kim, S. S., Lee, J. G., Kim, D. W., et al. (2011) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2011.26.3.285 · Cited by 30
Effect of ghrelin on glucose regulation in mice
Chacko, S. K., Haymond, M. W., Sun, Y., Marini, J. C., Sauer, P. J. J., Ma, X., & Sunehag, A. L. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00445.2011 · Cited by 31
Chon, S., Oh, S., Kim, S. W., Kim, J., Kim, Y. S., & Woo, J. (2010) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2010.25.3.273 · Cited by 30
Murri, M., García‐Delgado, R., Alcázar-Ramírez, J., Fernández-Ramos, A. M., Alcaide, J., Cardona, F., & Tinahones, F. J. (2011) · Respiratory Care · doi:10.4187/respcare.01081 · Cited by 30
Gambineri, A., Fanelli, F., Tomassoni, F., Munarini, A., Pagotto, U., Andrew, R., Walker, B. R., & Pasquali, R. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-1030 · Cited by 30
Vergotine, Z., Yako, Y. Y., Kengne, A. P., Erasmus, R. T., & Matsha, T. E. (2014) · BMC Genetics · doi:10.1186/1471-2156-15-10 · Cited by 30
Lifestyle and weight predictors of a healthy overweight profile over a 20‐year follow‐up
Fung, M., Canning, K. L., Mirdamadi, P., Ardern, C. I., & Kuk, J. L. (2015) · Obesity · doi:10.1002/oby.21087 · Cited by 30
Traurig, M. T., Hanson, R. L., Marinelarena, A. M., Kobes, S., Piaggi, P., Cole, S. A., Curran, J. E., Blangero, J., Göring, H. H. H., Kumar, S., et al. (2015) · Diabetes · doi:10.2337/db15-0571 · Cited by 29
Serum Vitamin D Concentrations Are Not Associated with Insulin Resistance in Swiss Adults
Marques-Vidal, P. M., Vollenweider, P., Guessous, I., Henry, H., Boulat, O., Waeber, G., & Jornayvaz, F. R. (2015) · Journal of Nutrition · doi:10.3945/jn.115.211763 · Cited by 31
Relationship between vitamin D and body fat distribution evaluated by DXA in postmenopausal women
Andreozzi, P., Verrusio, W., Viscogliosi, G., Summa, M. L., Gueli, N., Cacciafesta, M., & Albanese, C. V. (2015) · Nutrition · doi:10.1016/j.nut.2015.12.029 · Cited by 30
Yaron, M., Izkhakov, E., Sack, J., Azzam, I., Osher, E., Tordjman, K. M., Stern, N., & Greenman, Y. (2016) · Pituitary · doi:10.1007/s11102-016-0710-9 · Cited by 30
Histopathologic and metabolic effect of ursodeoxycholic acid treatment on PCOS rat model
Gözükara, İ., Dokuyucu, R., Özgür, T., Özcan, O., Pınar, N., Kurt, R. K., Kucur, S. K., & Dolapçıoğlu, K. (2016) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1134478 · Cited by 30
Petta, S., Ferraro, D., Cammà, C., et al. (2012) · Antiviral Therapy · doi:10.3851/imp2100 · Cited by 30
Prepregnancy Adverse Lipid Profile and Subsequent Risk of Gestational Diabetes
Han, E. S., Krauss, R. M., Xu, F., Sridhar, S. B., Ferrara, A. M., Quesenberry, C. P., & Hedderson, M. M. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3904 · Cited by 32
Wang, T., Huang, T. T. ‐., Zheng, Y., Rood, J., Bray, G. A., Sacks, F. M., & Qi, L. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.41 · Cited by 29
Kemp, A. H., López, S. R., Passos, V. M. D. A., Bittencourt, M. S., Dantas, E. M., Mill, J. G., Ribeiro, A. L. P., Thayer, J. F., Benseñor, I. M., & Lotufo, P. A. (2016) · Biological Psychology · doi:10.1016/j.biopsycho.2016.04.006 · Cited by 31
de Luis, D. A., Ovalle, H. F., Díaz-Soto, G., Izaola, O., de la Fuente, B., & Romero, E. (2014) · Journal of Investigative Medicine · doi:10.2310/jim.0000000000000032 · Cited by 31
Kim, K. E., Cho, Y. S., Baek, K. S., Li, L., Baek, K., Kim, J., Kim, H.-S., & Sheen, Y. H. (2016) · Korean Journal of Pediatrics · doi:10.3345/kjp.2016.59.5.231 · Cited by 33
Andersen, M. K., Jørsboe, E., Sandholt, C. H., Grarup, N., Jørgensen, M. E., Færgeman, N. J., Bjerregaard, P., Pedersen, O. B., Moltke, I., Hansen, T. F., et al. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006119 · Cited by 30
Ormseth, M. J., Yancey, P. G., Yamamoto, S., Oeser, A. M., Gebretsadik, T. S., Shintani, A., Linton, M. F., Fazio, S., Davies, S. S., Roberts, L. J., et al. (2016) · IJC Metabolic & Endocrine · doi:10.1016/j.ijcme.2016.08.002 · Cited by 31
Yashiro, H., Takagahara, S., Tamura, Y. O., Miyahisa, I., Matsui, J., Suzuki, H., Ikeda, S., & Watanabe, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166198 · Cited by 31
Tian, J., Lian, F., Yang, L., & Tong, X. (2017) · Journal of Diabetes · doi:10.1111/1753-0407.12559 · Cited by 30
Khedr, N. F., & Khedr, E. G. (2017) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12297 · Cited by 30
Cicero, A. F. G., Fogacci, F., Morbini, M., Colletti, A., Bove, M., Veronesi, M., Giovannini, M., & Borghi, C. (2017) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-017-0206-3 · Cited by 31
Kim, J. E., Dunville, K., Li, J.-J., Cheng, J.-X., Conley, T., Couture, C. S., & Campbell, W. (2017) · Endocrinology and Metabolism · doi:10.3803/enm.2017.32.2.257 · Cited by 29
Kleist, B., Wahrburg, U., Stehle, P., Schomaker, R., Greiwing, A., Stoffel‐Wagner, B., & Egert, S. (2017) · Journal of Nutrition · doi:10.3945/jn.117.251744 · Cited by 29
Complement C3 and fatty liver disease in Rheumatoid arthritis patients: a cross-sectional study
Ursini, F., Russo, E., Mauro, D., et al. (2017) · European Journal of Clinical Investigation · doi:10.1111/eci.12798 · Cited by 30
Alsebaey, A., Elhelbawy, M., & Waked, I. A. (2017) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001013 · Cited by 30
Grunewald, Z. I., Winn, N. C., Gastecki, M. L., Woodford, M. L., Ball, J. R., Hansen, S. A., Sacks, H. S., Vieira‐Potter, V. J., & Padilla, J. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00332.2017 · Cited by 26
Liang, S., Yu, Z., Song, X., Wang, Y., Li, M., & Xue, J. (2018) · Hormone and Metabolic Research · doi:10.1055/s-0043-124970 · Cited by 31
Physical Inactivity from Youth to Adulthood and Risk of Impaired Glucose Metabolism
Kallio, P., Pahkala, K., Heinonen, O. J., Tammelin, T., Hirvensalo, M. H., Telama, R., Juonala, M., Magnussen, C. G., Rovio, S., Helajärvi, H., et al. (2018) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000001555 · Cited by 31
Buko, V., Zavodnik, I. B., Kaniuka, O., Belonovskaya, E., Naruta, E. E., Lukivskaya, O., Kirko, S. N., Budryn, G., Żyżelewicz, D., Oracz, J., et al. (2018) · Food & Function · doi:10.1039/c7fo01823a · Cited by 30
Hassan, N. A., El‐Bassossy, H. M., Fahmy, A., & Mahmoud, M. F. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.03.044 · Cited by 31
Souteiro, P., Belo, S., Oliveira, S. C., Neves, J. S., Magalhães, D. M. D. S., Pedro, J. M. P., Bettencourt‐Silva, R., Costa, M. M., Varela, A. T. I. F., Queirós, J., et al. (2018) · Andrologia · doi:10.1111/and.13035 · Cited by 31
Weech, M., Altowaijri, H., Mayneris‐Perxachs, J., Vafeiadou, K., Madden, J., Todd, S., Jackson, K. G., Lovegrove, J. A., & Yaqoob, P. (2018) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy018 · Cited by 30
Rodrigues, A. P. D. S., Rosa, L. P. S., & Silveira, É. A. (2018) · Nutrition & Metabolism · doi:10.1186/s12986-018-0289-4 · Cited by 30
Zamani, N., Shams, M., Nimrouzi, M., et al. (2018) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2018.09.010 · Cited by 30
Rae, D. E., Pienaar, P. R., Henst, R. H. P., Roden, L. C., & Goedecke, J. H. (2018) · Sleep Health · doi:10.1016/j.sleh.2018.08.005 · Cited by 30
Francisco, C. D. O., Beltrame, T., Hughson, R. L., Milan‐Mattos, J. C., Ferroli-Fabrício, A. M., Benze, B. G., Ferraresi, C., Parizotto, N. A., Bagnato, V. S., Borghi‐Silva, A., et al. (2018) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2018.11.015 · Cited by 32
Rajagopal, G., Bhaskaran, R. S., & Balasubramanian, K. (2018) · Journal of Applied Toxicology · doi:10.1002/jat.3764 · Cited by 30
Serum omentin-1 levels in obese children
Zengi, S., Zengi, O., Kırankaya, A., et al. (2019) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2018-0231 · Cited by 30
Vasques, A. C. J., Cassani, R. S. L., Forti, A. C. E., Vilela, B. S., Pareja, J. C., Tambascia, M. A., Geloneze, B., & BRAMS Investigators (2015) · PLoS ONE · doi:10.1371/journal.pone.0125365 · Cited by 30
Erkin‐Cakmak, A., Bains, Y., Caccavello, R. J., Noworolski, S. M., Schwarz, J., Mulligan, K. M., Lustig, R. H., & Gugliucci, A. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02772 · Cited by 30
Jung, S. Y., Papp, J. C., Sobel, E. M., Yu, H., & Zhang, Z. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3688 · Cited by 30
Solitary kidney and risk of chronic kidney disease
Kim, S., Chang, Y., Lee, Y. R., Jung, H. S., Hyun, Y. Y., Lee, K., Joo, K. J., Yun, K. E., Shin, H. C., & Ryu, S. (2019) · European Journal of Epidemiology · doi:10.1007/s10654-019-00520-7 · Cited by 30
das Mercês, M. C., Santana, A. I. C., Lua, I., da Silva, D. A. R., Silva, D. D. S. E., Gomes, A. M. T., Miranda, M. C. D. M., Barbosa, C. D. S., dos Santos, L. N., Coelho, J. M. F., et al. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16152686 · Cited by 30
Decharatchakul, N., Settasatian, C., Settasatian, N., Komanasin, N., Kukongviriyapan, U., Intharaphet, P., & Senthong, V. (2019) · PeerJ · doi:10.7717/peerj.7407 · Cited by 32
Plasma Metabolomics to Identify and Stratify Patients With Impaired Glucose Tolerance
Wildberg, C., Masuch, A., Budde, K., Kastenmüller, G., Artati, A., Rathmann, W., Adamski, J., Kocher, T., Völzke, H., Nauck, M. A., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01104 · Cited by 28
Polysomnography and Treatment-Related Outcomes of Childhood Sleep Apnea
Isaiah, A., Pereira, K. D., & Das, G. (2019) · Pediatrics · doi:10.1542/peds.2019-1097 · Cited by 27
Toppala, S., Ekblad, L. L., Lötjönen, J. M. P., Helin, S., Hurme, S. A. M., Johansson, J. J., Jula, A., Karrasch, M., Koikkalainen, J. R., Laine, H. K., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190691 · Cited by 32
Tinahones, F. J., Fernández-García, J., Molina‐Vega, M., Asenjo‐Plaza, M., Banderas-Donaire, M. J., Hernández-Ollero, M., Rodríguez-Moreno, S., Álvarez‐Millán, J. J., Cabezas-Sánchez, P., Cardona, F., et al. (2019) · Asian Journal of Andrology · doi:10.4103/aja.aja_106_19 · Cited by 30
Rossen, J., Rosen, P., Johansson, U., Brismar, K., & Hagströmer, M. (2019) · The Physician and Sportsmedicine · doi:10.1080/00913847.2019.1684811 · Cited by 30
Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes
Ramin‐Mangata, S., Wargny, M., Pichelin, M., May, C. L., Thedrez, A., Blanchard, V., Nativel, B., Santos, R. D., Benseñor, I. M., Lotufo, P. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.11.027 · Cited by 33
Cardiorespiratory Fitness, Physical Activity, and Insulin Resistance in Children
Haapala, E. A., Wiklund, P., Lintu, N., Tompuri, T., Väistö, J., Finni, T. J., Tarkka, I. M., KEMPPAINEN, T., BARKER, A. R., Ekelund, U., et al. (2019) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000002216 · Cited by 30
Rothermel, J., Lass, N., Barth, A. C. R., et al. (2019) · Pediatric Obesity · doi:10.1111/ijpo.12605 · Cited by 30
Identifying the insulin resistance index in nondiabetic Chinese subjects
Tuo, X., Yuan, J., Wang, X., & Zhong, X. (2020) · Medicine · doi:10.1097/md.0000000000019023 · Cited by 30
Shanely, R. A., Zwetsloot, J. J., Jurrissen, T. J., Hannan, L., Zwetsloot, K. A., Needle, A. R., Bishop, A. E., Wu, G., & Perkins-Veazie, P. M. (2020) · Nutrition Research · doi:10.1016/j.nutres.2020.02.005 · Cited by 30
Insulin secretory defect may be the major determinant of GDM in lean mothers
Alam, M. F., Sharmin-Jahan, Hasan, M., Sultana, N., Mohona-Zaman, Rakibul-Hasan, M., Fariduddin, M., & Hasanat, M. A. (2020) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2020.100226 · Cited by 34
Mehreen, T. S., Kamalesh, R., Pandiyan, D., Kumar, D. S., Anjana, R. M., Mohan, V., & Ranjani, H. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0109 · Cited by 29
Russo, M., Marquez, A., Herrera, H., Mukdsi, M. C. A., Saavedra, L., Hebert, E. M., Gauffin-Cano, P., & Medina, R. B. (2020) · Food & Function · doi:10.1039/d0fo00730g · Cited by 29
Vogel, C. E., Crovesy, L., Rosado, E. L., & Soares-Mota, M. (2020) · Food & Function · doi:10.1039/d0fo00872a · Cited by 30
Johansen, M. Y., Karstoft, K., MacDonald, C., Hansen, K. B., Ellingsgaard, H., Hartmann, B., Albrechtsen, N. J. W., Vaag, A. A., Holst, J. J., Pedersen, B. K., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05249-7 · Cited by 34
Gerosa-Neto, J., Monteiro, P. A., Inoue, D. S., Antunes, B. M., Batatinha, H., Dorneles, G. P., Peres, A., Neto, J. C. R., & Lira, F. S. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155249 · Cited by 32
Yoon, J. H., Hong, A. R., Choi, W., et al. (2020) · Calcified Tissue International · doi:10.1007/s00223-020-00761-9 · Cited by 30
Brulport, A., Corre, L. L., Maquart, G., Barbet, V., Dastugue, A., Séverin, I., Vaiman, D., & Chagnon, M. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.116243 · Cited by 30
Zhang, E. W., Chai, J. C., Deik, A., Hua, S., Sharma, A., Schneider, M. F., Gustafson, D., Hanna, D. B., Lake, J. E., Rubin, L. H., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab011 · Cited by 31
Zhang, L., Li, G., She, Y., & Zhang, Z. (2021) · Practical Laboratory Medicine · doi:10.1016/j.plabm.2021.e00207 · Cited by 31
Body Composition Changes with Long-term Pegvisomant Therapy of Acromegaly
Kuker, A. P., Shen, W., Jin, Z., Singh, S., Chen, J., Bruce, J. N., & Freda, P. U. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab004 · Cited by 31
Kumar, S., Chowdhury, S., Razdan, A., Kumari, D., Purty, R. S., Ram, H., Kumar, P., Nayak, P., & Shukla, S. D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.595471 · Cited by 30
Salman, A., Salman, M. A., Marie, M. A. S., Rabiee, A., Helmy, M. Y., Tourky, M. S., Qassem, M. G., Shaaban, H. E., & Sarhan, M. D. (2021) · Scientific Reports · doi:10.1038/s41598-021-85450-9 · Cited by 34
Piché, M., Clavel, M.-A. A., Auclair, A., Rodríguez-Flores, M., O’Connor, K., Garceau, P., Rakowski, H., & Poirier, P. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154773 · Cited by 30
Abdesselam, A., Zidoum, H. M., Zadjali, F., Hedjam, R., Al-Ansari, A., Bayoumi, R., Al‐Yahyaee, S., Hassan, M. O., & Albarwani, S. (2021) · Sultan Qaboos University medical journal · doi:10.18295/squmj.4.2021.030 · Cited by 32
Measuring Insulin Resistance in Humans
Sharma, V. R., Matta, S. T., Haymond, M. W., & Chung, S. T. (2020) · Hormone Research in Paediatrics · doi:10.1159/000515462 · Cited by 38
Pirfenidone modifies hepatic miRNAs expression in a model of MAFLD/NASH
Escutia-Gutiérrez, R., Rodríguez-Sanabria, J. S., Monraz-Méndez, C. A., Garcia-Bañuelos, J. J., Santos, A., Sandoval-Rodriguez, A. S., & Armendáriz‐Borunda, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-91187-2 · Cited by 31
Ruiz, H. H., Nguyen, A. T., Wang, C., He, L., Li, H., Hallowell, P. T., McNamara, C. A., & Schmidt, A. M. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-00878-3 · Cited by 32
Liu, Y., Kuang, A., Bain, J. R., Muehlbauer, M. J., Ilkayeva, O., Lowe, L. P., Metzger, B. E., Newgard, C. B., Scholtens, D. M., & Lowe, W. L. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab513 · Cited by 31
Jung, Y., Koo, B. K., Jang, S. Y., Kim, D. R., Lee, H., Lee, D. H., Joo, S. K., Jung, Y. J., Park, J. H., Yoo, T., et al. (2021) · Liver International · doi:10.1111/liv.15030 · Cited by 29
Ku, E. J., Lee, D., Jeon, H. J., & Oh, T. K. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109123 · Cited by 35
Shen, D., Lu, Y., Tian, S., Ma, S., Sun, J. Y., Hu, Q., Pang, X., & Li, X. (2021) · Journal of Food Biochemistry · doi:10.1111/jfbc.13991 · Cited by 30
Arias-Córdova, Y., Blé‐Castillo, J. L., García-Vázquez, C., et al. (2021) · Nutrients · doi:10.3390/nu13114052 · Cited by 30
Petersen, K. F., Dufour, S., Li, F., Rothman, D. L., & Shulman, G. I. (2022) · JCI Insight · doi:10.1172/jci.insight.157906 · Cited by 32
Ozen, E., Mihaylova, R., Weech, M., Kinsella, S., Lovegrove, J. A., & Jackson, K. G. (2022) · Nutrition & Metabolism · doi:10.1186/s12986-022-00650-y · Cited by 36
Sullivan, B. P., Nie, Y., Evans, S., Kargl, C. K., Hettinger, Z. R., Garner, R. T., Hubal, M. J., Kuang, S., Stout, J., & Gavin, T. P. (2022) · Experimental Physiology · doi:10.1113/ep090062 · Cited by 33
Hyperglycemia and Loss of Redox Homeostasis in COVID-19 Patients
Soto, M. E., Guarner‐Lans, V., Díaz‐Díaz, E., Manzano-Pech, L., Chavarría, A. P., Valdez‐Vázquez, R. R., Aisa-Álvarez, A., Saucedo‐Orozco, H., & Pérez-Torres, I. (2022) · Cells · doi:10.3390/cells11060932 · Cited by 31
Hosseinpour‐Niazi, S., Mirmiran, P., Hadaegh, F., Mahdavi, M., Khalili, D., DANESHPOUR, M. S., Momenan, A. A., & Azizi, F. (2022) · European Journal of Nutrition · doi:10.1007/s00394-022-02869-0 · Cited by 33
Cardiovascular Risk Factors and Target Organ Damage in Adolescents: The SHIP AHOY Study
Price, J. J., Urbina, E. M., Carlin, K. E., Becker, R. C., Daniels, S. R., Falkner, B. E., Ferguson, M. A., Hanevold, C. D., Hooper, S. R., Ingelfinger, J. R., et al. (2022) · PEDIATRICS · doi:10.1542/peds.2021-054201 · Cited by 31
Foss‐Freitas, M. C., Akıncı, B., Neidert, A., Bartlett, V. J., Hurh, E., Karwatowska‐Prokopczuk, E., & Oral, E. A. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01589-4 · Cited by 31
Jazwiec, P. A., Patterson, V. S., Ribeiro, T. A., Yeo, E., Kennedy, K. M., Mathias, P. C. D. F., Petrik, J., & Sloboda, D. M. (2022) · Biology of Reproduction · doi:10.1093/biolre/ioac066 · Cited by 43
Risk of liver fibrosis in patients with prediabetes and diabetes mellitus
Park, J., Kwon, H., Sohn, W., Cho, J., Park, S. J., Chang, Y., Ryu, S., Kim, B. I., & Cho, Y. K. (2022) · PLoS ONE · doi:10.1371/journal.pone.0269070 · Cited by 30
Yu, R., Wang, Z., Ma, M., Xu, P., Liu, L., Tinkov, A. A., Lei, X. G., & Zhou, J. (2022) · Antioxidants · doi:10.3390/antiox11071263 · Cited by 32
Lee, C.-L., Liu, W.-J., & Tsai, S. (2022) · Nutrients · doi:10.3390/nu14142832 · Cited by 31
Reduced leukocyte mitochondrial copy number in metabolic syndrome and metabolically healthy obesity
Agius, R., Pace, N. P., & Fava, S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.886957 · Cited by 31
Braun, J. M., Papandonatos, G. D., Li, N., Sears, C. G., Buckley, J. P., Cecil, K. M., Chen, A., Eaton, C. B., Kalkwarf, H. J., Kelsey, K. T., et al. (2022) · Environmental Research · doi:10.1016/j.envres.2022.114021 · Cited by 32
Seo, J. Y., Cho, E. J., Kim, M. J., Kwak, M., Yang, J. I., Chung, S. J., Yim, J. Y., Yoon, J. W., & Chung, G. E. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13099 · Cited by 29
de Avila, L., Henry, L. L., Paik, J. M., Ijaz, N., Weinstein, A. A., & Younossi, Z. M. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.01.006 · Cited by 30
One-hour glucose is an earlier marker of dysglycemia than two-hour glucose
Ha, J., Chung, S. T., Bogardus, C., Jagannathan, R., Bergman, M., & Sherman, A. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110839 · Cited by 31
Wang, L., Lin, P., Ma, A., Zheng, H., Wang, K., Li, W., Wang, C., Zhao, R., Liang, K., Liu, F., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127112 · Cited by 31
Pan, C. Y., So, W., Khalid, B. A. K., Mohan, V., Thai, A. C., Zimmet, P., Cockram, C. S., Jørgensen, L. N., Yeo, J. P., & The ASDIAB Study Group (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01287.x · Cited by 30
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
